- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4167
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Savior Lifetec Corporation · Healthcare · Biotechnology
Latest close
19.15 TWD
-3.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 5.9% above the Trend Line and sits at 79.7% of its 52-week range. The latest completed week returned -3.0%, after a 3.4% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
43
out of 100
Latest Close
19.15 TWD
14 Aug 2026
1W Return
-3.0%
latest completed week
4W Return
3.4%
short-term follow-through
12W Return
11.8%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Next-week expectancy is negative at 38.97% based on similar historical setup states.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.0%
Latest completed week; four-week move 3.4%.
Indicator stack
32/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.97%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 5.9% above the Trend Line and sits at 79.7% of its 52-week range. The latest completed week returned -3.0%, after a 3.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5812-week average 0.45
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 3.4% over four weeks, 11.8% over 12 weeks, and 11.8% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.54Latest activity-pressure read.
Pressure change142.5%Four-week change in activity pressure.
Leadership-20.68Latest relative-leadership reading.
RS change2.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.5%Distance below the 52-week high.
13-week volatility6.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+16.9%Week of 7 Aug.
Worst week-8.5%Week of 31 Jul.
Latest week-3.0%Week of 14 Aug.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks1
Modest losses11
Sharp losses3
Recent vol6.4%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split21/29Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank32 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank22 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis49/100Latest 12-week confirmation: trend 10/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.58; No reversal markers Next-Week ExpectancyNegative 38.97%Next-week expectancy is negative with a 38.97% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 19.15 TWD | -3.0% | 18.08 TWD | 17.74 TWD | 0.54 | -20.68 | 4.8M | On |
| 7 Aug 2026 | 19.75 TWD | 16.9% | 18.02 TWD | 17.72 TWD | 0.52 | -16.16 | 6.8M | On |
| 31 Jul 2026 | 16.90 TWD | -8.5% | 17.90 TWD | 17.69 TWD | 0.40 | -27.25 | 6.9M | Off |
| 24 Jul 2026 | 18.48 TWD | -0.2% | 17.86 TWD | 17.67 TWD | 0.54 | -22.37 | 4.6M | On |
| 17 Jul 2026 | 18.52 TWD | -1.4% | 17.76 TWD | 17.65 TWD | 0.22 | -21.23 | 7.4M | On |
| 10 Jul 2026 | 18.79 TWD | 0.0% | 17.66 TWD | 17.63 TWD | -0.07 | -25.59 | 8.3M | On |
| 3 Jul 2026 | 18.79 TWD | 10.6% | 17.58 TWD | 17.62 TWD | -0.32 | -28.66 | 8.2M | On |
| 26 Jun 2026 | 17.00 TWD | -5.0% | 17.50 TWD | 17.59 TWD | -0.37 | -33.06 | 4.7M | On |
| 19 Jun 2026 | 17.89 TWD | 0.5% | 17.45 TWD | 17.58 TWD | -0.26 | -33.30 | 2.6M | On |
| 12 Jun 2026 | 17.80 TWD | -3.9% | 17.40 TWD | 17.56 TWD | -0.34 | -31.14 | 6.4M | On |
| 5 Jun 2026 | 18.52 TWD | 4.8% | 17.35 TWD | 17.54 TWD | -0.49 | -30.85 | 8.4M | On |
| 29 May 2026 | 17.67 TWD | 3.1% | 17.24 TWD | 17.52 TWD | -0.80 | -34.53 | 6.5M | Off |
| 22 May 2026 | 17.13 TWD | 1.1% | 17.17 TWD | 17.50 TWD | -0.98 | -33.82 | 3.2M | Off |
| 15 May 2026 | 16.95 TWD | 0.8% | 17.12 TWD | 17.49 TWD | -0.92 | -33.69 | 4.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.